All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
VivoCAR™ Anti-MUC1 (1B2) h(CD28-41BB-CD3z) CAR circRNA is specifically designed to overcome the physical barriers of the glycocalyx in adenocarcinomas. The 1B2 clone is vital for its high-affinity binding to the peptide core of MUC1, enabling in vivo generated CAR-T cells to penetrate the dense mucin layer of solid tumors. By utilizing the non-integrating circRNA platform, this product offers a transient but high-intensity therapeutic pulse, allowing researchers to study immediate tumor debulking while ensuring that CAR expression naturally tapers off to prevent long-term impact on healthy secretory tissues.
There are currently no customer reviews or questions for VivoCAR™ Anti-MUC1 (1B2) h(CD28-41BB-CD3z) CAR circRNA (XS-1225-YX50). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION